Immunoaugmentative therapy.
D000914:Antibodies, Viral / Q000032:analysis; D001444:Bahamas; D001798:Blood Proteins / Q000032:analysis; D000529:Complementary Therapies; D004340:Drug Contamination; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects; D009369:Neoplasms / Q000628:therapy*
D000914:Antibodies, Viral; D001798:Blood Proteins; D006514:Hepatitis B Surface Antigens